BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ozdilek B, Demircan B. Serum microRNA expression levels in Turkish patients with Parkinson's disease. Int J Neurosci 2020;:1-9. [PMID: 32546033 DOI: 10.1080/00207454.2020.1784165] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ardashirova NS, Abramycheva NY, Fedotova EY, Illarioshkin SN. MicroRNA Expression Profile Changes in the Leukocytes of Parkinson’s Disease Patients. Acta Naturae 2022;14:79-84. [DOI: 10.32607/actanaturae.11729] [Reference Citation Analysis]
2 Zhang H, Yao L, Zheng Z, Koc S, Lu G. The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement. Pharmaceuticals 2022;15:811. [DOI: 10.3390/ph15070811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang W, Wang Y, Yao Y, Zhang G, Zhang Y, Gao S. Circulating microRNAs as potential biomarkers for the diagnosis of Parkinson's disease: A meta-analysis. Neurología 2022. [DOI: 10.1016/j.nrl.2022.03.002] [Reference Citation Analysis]
4 Zhang P, Rasheed M, Liang J, Wang C, Feng L, Chen Z. Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review. Front Aging Neurosci 2022;14:819836. [DOI: 10.3389/fnagi.2022.819836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Xu A, Kouznetsova VL, Tsigelny IF. Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning. J Alzheimers Dis 2022. [PMID: 35147545 DOI: 10.3233/JAD-215502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kuo MC, Liu SC, Hsu YF, Wu RM. The role of noncoding RNAs in Parkinson's disease: biomarkers and associations with pathogenic pathways. J Biomed Sci 2021;28:78. [PMID: 34794432 DOI: 10.1186/s12929-021-00775-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
7 Manna I, Quattrone A, De Benedittis S, Iaccino E, Quattrone A. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease. J Parkinsons Dis 2021. [PMID: 34334422 DOI: 10.3233/JPD-212726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chen Q, Deng N, Lu K, Liao Q, Long X, Gou D, Bi F, Zhou J. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease. Sci Rep 2021;11:15268. [PMID: 34315950 DOI: 10.1038/s41598-021-94734-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
9 Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review. Front Neurosci 2021;15:660379. [PMID: 33994934 DOI: 10.3389/fnins.2021.660379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
10 Kamenova S, Aralbayeva A, Kondybayeva A, Akimniyazova A, Pyrkova A, Ivashchenko A. Evolutionary Changes in the Interaction of miRNA With mRNA of Candidate Genes for Parkinson's Disease. Front Genet 2021;12:647288. [PMID: 33859673 DOI: 10.3389/fgene.2021.647288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Acharya S, Salgado-Somoza A, Stefanizzi FM, Lumley AI, Zhang L, Glaab E, May P, Devaux Y. Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease. Int J Mol Sci 2020;21:E6513. [PMID: 32899928 DOI: 10.3390/ijms21186513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]